Creating a New Kind of Doctor
We recruit and train physician leaders as comfortable taking on systemic challenges in health as caring for individual patients.
ARE YOU ONE?
Discovery to Impact — Faster
We reward creative thinking and encourage rapid experimentation, using collaborative programs to speed promising research to market.
SEE HOW
Improving Care. Improving Health.
We’re here to make health — including health care — better. The end goal is a complete revolution in how people get and stay healthy.
WHAT IT MEANS
In This Section
More Information
GET CARE
Health in the Landscape of Life
Enabling the healthscape, the ecosystem outside the clinic, requires improving the system to pay for health drivers.
EXPLORE FURTHER
More Information
DEVELOP A PRODUCT
Meet Dell Med
We’re rethinking the role of academic medicine in improving health — and doing so with a unique focus on our community.
ABOUT US
More Information
EXPLORE
Make an Appointment Give Faculty Students Alumni Directory
CME

Psychiatry & Behavioral Sciences Grand Rounds: Forensic Evaluation of Asylum Seekers

Location: Health Discovery Building Auditorium (HDB 1.208)

Address: 1601 Trinity St., Bldg. B, Austin, Texas 78712 | View Map »

Date: Tuesday, October 17, 2023

Time: 12–1:30 p.m.

Contact: Jennifer Braham

About the Event

In this installment of Psychiatry and Behavioral Sciences Grand Rounds, Alisa R. Gutman, M.D., Ph.D., presents “Forensic Evaluation of Asylum Seekers.” Gutman is the medical director for the Penn Human Rights Clinic and a clinical assistant professor in the Department of Psychiatry at Perelman School of Medicine of the University of Pennsylvania.

For more information about the event, email Jennifer Braham.

Upon request, Dell Medical School will provide interpretation services at this event. Please notify Jennifer by Sept. 28, 2023, if interpretation is needed.

Learning Objectives

By the end of this presentation, the audience participant should be able to:

  1. Discuss the legal basis for seeking asylum in the United States.
  2. Describe the components of a forensic asylum evaluation.
  3. Identify how and why forced migration can impact a person’s mental health and well-being.

Target Audience

  • Primary: Psychiatrists, social workers, psychologists, nurses and other mental health professionals
  • Secondary: Other health care professionals

Attributes/Competencies

This activity has been designed to promote some of the following desired physician attributes and competencies:

  • ACGME: Patient Care; Medical Knowledge; Practice-Based Learning and Improvement; Interpersonal and Communication Skills; Professionalism; Systems-Based Practice.
  • IOM: Provide patient-centered; Work in interdisciplinary teams; Employ evidenced-based practice; Apply quality improvement; Utilize informatics
  • IECC: Interprofessional Teamwork & Team-based Practice; Interprofessional Communication; Values & Ethics for Interprofessional Practice

Speaker Disclosure

Alisa R. Gutman, M.D., Ph.D., speaker for this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Planner Disclosure

Mark H. Townsend, M.D., M.S.; Carol L. Alter, M.D.; Lloyd S. Berg, Ph.D., ABPP; Octavio N. Martinez Jr., M.D., MPH; Barbara Springer; and Jennifer Braham, M.S., planners for this educational activity, have no relevant financial relationship(s) with ineligible companies to disclose.

Jeffrey Newport, M.D., M.S., MDiv, planner for this educational activity, received grants/research support from Navitor Pharmaceuticals and Sage Therapeutics, and he is a consultant for Sage Therapeutics. He received an honorarium for serving on the advisory board of Sage Therapeutics, Merck and Janssen.

Charles B. Nemeroff, M.D., Ph.D., planner for this educational activity, is a consultant for ANeuroTech (division of Anima BV), Signant Health, Janssen Research & Development LLC, BioXcel Therapeutics, Silo Pharma, Engrail Therapeutics, Clexio Bioscience LTD, EcoR1 Capital LLC, EmbarkNeuro (formerly AncoraBio), Galen Mental Health LLC, Goodcap Pharmaceuticals Inc., ITI Inc., LUCY Scientific Discovery, Relmada Therapeutics Inc., Sage Therapeutics, Senseye Inc., and Precisement Health. He is a stock shareholder (directly purchased) of Xhale, Seattle Genetics, Antares, BI Gen Holdings Inc., Corcept Therapeutics Pharmaceuticals Company, EMA Wellness, Precisement Health, and Relmada Therapeutics Inc. Nemeroff is on the scientific advisory boards for ANeuroTech (division of Anima BV), Signant Health, Laureate Institute for Brain Research (LIBR) Inc., Galen Mental Health, LLC, Heading Health, LLC, Pasithea Therapeutics Corp, Sage Therapeutics, Inc and Senseye, Inc. He holds patents for the following: Method and devices for transdermal delivery of lithium (US 6,375,990B1), Method of assessing antidepressant drug therapy via transport inhibition of monoamine neurotransmitters by ex vivo assay (US 7,148,027B2).

The CME Advisory Committee, reviewers of this educational activity, have no relevant financial relationship(s) with ineligible companies to disclose.

All the relevant financial relationships listed for these individuals have been mitigated.

Accreditation Statement

The University of Texas at Austin Dell Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Texas at Austin Dell Medical School designates this internet live course for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.